CERo Therapeutics Holdings, Inc. (CERO) NASDAQ

7.20

-0.02(-0.28%)

Updated at July 30 12:22PM

Currency In USD

Valuation

Market Cap144.95M
Enterprise Value143.2M
P/E Ratio-0.88
PEG Ratio-0.02
Price/Sales Ratio0
Price/Book Ratio-37.25
Enterprise/Revenue0
Enterprise/EBITDA-0.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.74
Return On Equity6.61

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-6.57M
Net Income-7.73M
Diluted EPS-6.87

Balance Sheet

Total Cash5.2M
Total Cash/Share3.04
Total Debt1.37M
Total Debt/Equity-4.15
Current Ratio0.73
Book Value Per Share-0.19

Price History

52-Week Change-97.71
52-Week High896
52-Week Low6.71
Moving Average 50 Days9.33
Moving Average 200 Days85.52

Statistics

Average Volume1.14M
Shares Outstanding1.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 13, 2025